These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3953430)

  • 1. Short- and long-term treatment of mild to moderate hypertension with verapamil.
    Wicker P; Roudaut R; Gosse P; Dallocchio M
    Am J Cardiol; 1986 Feb; 57(7):83D-86D. PubMed ID: 3953430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mild to moderate hypertension with verapamil slow-release in outpatients. Collaborative Group of the Spanish League for the Fight Against Hypertension.
    Gómez Pajuelo C; Pérez Naranjo J; Ruiz Martínez I
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S50-2. PubMed ID: 2475687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-daily administration of oral verapamil in the treatment of essential hypertension.
    Frishman W; Charlap S; Kimmel B; Saltzberg S; Stroh J; Weinberg P; Monuszko E; Wiezner J; Dorsa F; Pollack S
    Arch Intern Med; 1986 Mar; 146(3):561-5. PubMed ID: 3954530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with verapamil and nitrendipine in patients with hypertension.
    Nalbantgil I; Onder R; Kiliçcioğlu B; Türkoğlu C
    J Hum Hypertens; 1993 Jun; 7(3):305-8. PubMed ID: 8345499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG; Fox AA; Stimpel M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging study.
    Carr AA; Bottini PB; Prisant LM; Fisher LD; Devane JG; O'Brien DE; Rhoades RB
    J Clin Pharmacol; 1991 Feb; 31(2):144-50. PubMed ID: 2010560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etozolin monotherapy and combination with verapamil in essential hypertension.
    Muiesan G; Agabiti-Rosei E
    J Hypertens Suppl; 1989 Dec; 7(6):S278-9. PubMed ID: 2698939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive and renal effects of orally administered verapamil.
    Leonetti G; Sala C; Bianchini C; Terzoli L; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):375-82. PubMed ID: 7002568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of resistant hypertension: 3 years of follow-up with the combination of verapamil and methyldopa.
    Spritzer N; Spritzer TS; Rodrigues R
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S65-7. PubMed ID: 2475692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study of verapamil in systemic hypertension in Thailand.
    Nontakanun S; Ngarmukos P; Sitthisook S; Jeam-Anukulkit N; Intharakoses A; Tanprasert P; Sansanayudth P; Sriratanaban A; Polsi Y
    Am J Cardiol; 1986 Feb; 57(7):106D-107D. PubMed ID: 3513511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
    Messerli F; Frishman WH; Elliott WJ
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study.
    Speders S; Sosna J; Schumacher A; Pfennigsdorf G
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S47-9. PubMed ID: 2475686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
    Di Somma S; Petitto M; Liguori V; Carotenuto A; Paulucci A; De Divitiis O
    Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB; Curran MP; Perry CM
    Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.